The Impact of Smoke Exposure on the Clinical Phenotype of Alpha-1 Antitrypsin Deficiency in Ireland: Exploiting a National Registry to Understand a Rare Disease

2015 ◽  
Vol 12 (sup1) ◽  
pp. 2-9 ◽  
Author(s):  
M. Emmet O’Brien ◽  
Kevin Pennycooke ◽  
Tomás P. Carroll ◽  
Jonathan Shum ◽  
Laura T. Fee ◽  
...  
Keyword(s):  
Rare Disease ◽  
Clinical Phenotype ◽  
National Registry ◽  
Smoke Exposure ◽  
Antitrypsin Deficiency ◽  
Alpha 1 Antitrypsin Deficiency ◽  
Alpha 1 Antitrypsin ◽  
The Impact

scholarly journals The TNFalpha gene relates to clinical phenotype in alpha-1-antitrypsin deficiency

2008 ◽  
Vol 9 (1) ◽  
Author(s):  
Alice M Wood ◽  
Matthew J Simmonds ◽  
Darren L Bayley ◽  
Paul R Newby ◽  
Stephen C Gough ◽  
...  
Keyword(s):  
Clinical Phenotype ◽  
Antitrypsin Deficiency ◽  
Alpha 1 Antitrypsin Deficiency ◽  
Alpha 1 Antitrypsin

Stem Cell Therapies in Reparative Medicine

2003 ◽  
Vol 12 (4) ◽  
pp. 329-334 ◽  
Author(s):  
Juan Domínguez-Bendala ◽  
Camillo Ricordi
Keyword(s):  
Developmental Biology ◽  
Stem Cell ◽  
Logical Consequence ◽  
Stem Cell Therapies ◽  
Cell Therapies ◽  
Novel Technologies ◽  
Antitrypsin Deficiency ◽  
Alpha 1 Antitrypsin Deficiency ◽  
Alpha 1 Antitrypsin ◽  
The Impact

The future implementation of stem cell therapies to treat conditions thus far considered incurable has been envisioned as logical consequence of the fast-paced progress in stem cell research over the last few years. Still, many practical obstacles stand in the way to the routine application of these novel technologies in medicine. The conference “Stem Cell Therapies in Reparative Medicine,” held aboard the cruise vessel Majesty of the Seas (Miami, USA- Nassau, Bahamas, April 19–22, 2002), focused on the analysis of these problems from different perspectives, including developmental biology (cell proliferation, fate determination, and enrichment), immunology (allorejection and prevention of autoimmunity recurrence), and clinical therapy, emphasizing the impact of stem cell technologies on the emerging field of tissue engineering and the treatment of alpha-1 antitrypsin deficiency.

Sign in / Sign up

Export Citation Format

Share Document